Status:
COMPLETED
Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
This study is conducted in Europe. The aim of this observational study is to gain practical experience with once daily Levemir® administration in type 2 diabetes patients who were previously treated w...
Eligibility Criteria
Inclusion
- Type 2 diabetic subjects on intensive insulin treatment (IIT)
- Eligibility for once daily insulin detemir administration
- Informed consent obtained before any observation-related activities
Exclusion
- Known or suspected allergy to insulin detemir
- Subjects previously enrolled in the observation
- Women who are pregnant, breast feeding or have the intention of becoming pregnant within 6 months
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00806897
Start Date
January 1 2009
End Date
December 1 2009
Last Update
November 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Vilnius, Lithuania, 01112